Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease.

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1975 • 3,051 citations

Evidence for the Secretion of an Osteoclast Stimulating Factor in Myeloma

1974 • 681 citations

Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma Cells

1987 • 386 citations

Histologic Classification and Staging of Multiple Myeloma: A Retrospective and Prospective Study of 674 Cases

1987 • 286 citations

Physiological senile involution and pathological rarefaction of bone

1973 • 275 citations

Staging and kinetics of multiple myeloma.

1986 • 215 citations

Quantitative histology of myeloma‐induced bone changes

1982 • 183 citations

Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients

1984 • 175 citations

Relation of Osteoclast Activating Factor Production to Extent of Bone Disease in Multiple Myeloma

1981 • 122 citations

Histochemical identification of osteoclasts. Review of current methods and reappraisal of a simple procedure for routine diagnosis on undecalcified human iliac bone biopsies.

1983 • 96 citations

Serum bone gla-protein in multiple myeloma

1987 • 70 citations

Importance of quantitative histology of bone changes in monoclonal gammopathy

1986 • 57 citations

Simultaneous Identification of Calcified Cartilage, Bone and Osteoid Tissue on Plastic Sections: New Polychrome Procedures Specially Adapted to Image Analyzer Systems

1986 • 19 citations

Clinical evaluation of response or escape to chemotherapy and of survival of patients with multiple myeloma. A prospective study of 202 patients (1975-1982).

1984 • 14 citations